| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |